Now showing items 1-1 of 1

    • Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins 

      Díez, José María; Romero, Carolina; Vergara-Alert, Júlia; Belló-Perez, Melissa; Rodon, Jordi; Honrubia, José Manuel; Segalés, Joaquim; Sola, Isabel; Enjuanes, Luis; Gajardo, Rodrigo (Immunotherapy, 2020-09-09) Sanitat Animal
      Background: Cross-reactivity against human coronaviruses with Flebogamma® DIF and Gamunex®-C, two available intravenous immunoglobulins (IVIG), has been reported. In this study, these IVIG were tested ...